CVR 44566141Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)Albusvej 7, 3650 ØlstykkeFounded 12 Jan 2024
Compare withsimilar companiesanother companyits industry
PhytoCuro ApS
CVR holds no employment figures for this company.
The newest trades with a company on a side are on the latest property trades.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Cite as: PhytoCuro ApS, https://dandex.ai/company/44566141/phytocuro. Source: Dandex, from CVR, read 22 Nov 2026.
Dandex is Danish Company Data. Connect it once and ask about PhytoCuro ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Dandex has an MCP server at https://dandex.ai/mcp and a REST API at https://dandex.ai/api/v1.
Set up DandexGross profit
62.3K
DKK, annual report 2024
Result
+52.1K
DKK, annual report 2024
Equity
92.1K
DKK, annual report 2024
Ce3 Holding ApSCVR 37073334, 33.3% to under 50% of capital and votes, until 30 Dec 2025
Sonne Buch Holding ApSCVR 44527162, 33.3% to under 50% of capital and votes, until 30 Dec 2025
and 1 moreMagnus Helvig Eriksenuntil 30 Dec 2025
Oliver Sonne Buchuntil 30 Dec 2025
Thomas Francois Antoine Vainuntil 30 Dec 2025
No current owner is registered.
CVR 3707333433.3% to under 50% of capital and votes12 Jan 2024 to 30 Dec 2025
CVR 4452716233.3% to under 50% of capital and votes12 Jan 2024 to 30 Dec 2025
CVR 4453879233.3% to under 50% of capital and votes12 Jan 2024 to 30 Dec 2025
CVR lists no current officers for this company.
Founded 12 Jan 2024.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
The company's own figures, in DKK, from the annual reports filed in XBRL.
| DKK thousands | 2024 |
|---|---|
| Gross profit | 62 |
| Operating profit | +52 |
| Result for the year | +52 |
| Equity | 92 |
| Total assets | 92 |
Annual report 2024
12 Jan 2024 to 31 Dec 2024, published 12 May 2025
Amounts in DKK.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| FoundingCashPaid in 40,000 | None | 40,000 | None | 40,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The company's own figures, in DKK, from the annual reports filed in XBRL.
| DKK thousands | 2024 |
|---|---|
| EBITDA | 52 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. |
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. |
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. |
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. |
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. |
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. |
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
How each credit metric is calculated:
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Source: CVR, read 22 Nov 2026.
2 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Virksomheden er opløst ved erklæring efter selskabslovens § 216, jf. lov om erhvervsdrivende virksomheder § 20
Direktion:
Fratrådte:
Oliver Sonne Buch, den 30.12.2025, Magnus Helvig Eriksen, den 30.12.2025, Thomas Francois Antoine Vain, den 30.12.2025.
Stiftelsesdato: 12.01.2024.
Virkningsdato: 12.01.2024.
Seneste vedtægtsdato: 12.01.2024.
Kapital:
kr. 40.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 40.000,00 til kurs 100,00, fuldt indbetalt.
Stiftere:
CVR-NR. 37073334 Ce3 Holding ApS, Nordre Strandvej 119G, 2., 3150 Hellebæk, den 12.01.2024, CVR-NR. 44527162 Sonne Buch Holding ApS, Albusvej 7, 2. mf, 3650 Ølstykke, den 12.01.2024, CVR-NR. 44538792 Vain ApS, Taarbækdalsvej 1C, 2930 Klampenborg, den 12.01.2024.
Direktion:
Oliver Sonne Buch, den 12.01.2024, Magnus Helvig Eriksen, den 12.01.2024, Thomas Francois Antoine Vain, den 12.01.2024.
Selskabet tegnes af den samlede direktion.
Første regnskabsår:
12.01.2024 - 31.12.2024.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 22 Nov 2026.
What Pro holds for PhytoCuro ApS:
Have Pro? Sign in.
P-number 1030007391Albusvej 7, 3650 Ølstykke